Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study by Pan, Jing, MD, Tang, Kaiting, BS, Luo, Yuechen, PhD, Seery, Samuel, PhD, Tan, Yue, BS, Deng, Biping, MS, Liu, Feng, MS, Xu, Xiuwen, MD, Ling, Zhuojun, MD, Song, Weiliang, MD, Xu, Jinlong, MD, Duan, Jiajia, MD, Wang, Zelin, MD, Li, Chunyu, MD, Wang, Kai, MD, Zhang, Yibing, BS, Yu, Xinjian, MD, Zheng, Qinlong, MD, Zhao, Liping, BS, Zhang, Jiecheng, BS, Chang, Alex H, PhD, Feng, Xiaoming, Prof

Get full text